Magazine Article | December 1, 2023

Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place

Source: Life Science Leader

By Ben Comer, Chief Editor, Life Science Leader

With the enthusiasm surrounding innovative product types and therapeutic approaches — and the corresponding rush to bring these new products to market — company leaders should double down on internal manufacturing and CDMO oversight to prevent unanticipated delays. Supply chain shortages are likely to continue next year, but biopharma leaders suggest that collaboration with government regulators can help grease the skids; in other scenarios, some of which are described below, operations executives have been able to turn other company’s shortages into their own opportunities.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader